Amwill Health Care Ltd vs Zenith Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Amwill Health Care Ltd is ₹ 36 as of 06 May 15:30 . The P/E Ratio of Amwill Health Care Ltd is 0 as of March 2022 .The P/E Ratio of Zenith Drugs Ltd is 0 as of March 2022 . The Market Cap of Amwill Health Care Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Zenith Drugs Ltd is ₹ 0 crore as of March 2022 . The Dividend Payout of Amwill Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenith Drugs Ltd changed from 8.99 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Amwill Health Care Ltd

Amwill Health Care Limited was originally incorporated on August 21, 2017 under the name Amwill Health Care Private Limited', dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore.
Further, Company was converted into a Public Limited Company and a fresh Certificate of Incorporation dated January 25, 2024 was issued by the Registrar of Companies, Karnataka at Bangalore with the change in name to Amwill Health Care Limited'. Amwill Health Care is a derma-cosmetic development company, associated with contract manufacturers, distributor and third party product development agencies, which has enabled in developing capabilities, in manufacturing, packaging and distribution.
Since inception, the focus has been on developing formulations which offer solutions to various dermatological disorders.

About Zenith Drugs Ltd

Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company as 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
Subsequently, Company was converted into Public Limited and consequently, the name of the Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
Zenith's core business centers on production of high-quality, cost-effective pharmaceutical formulations such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.
With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.

FAQs for the comparison of Amwill Health Care Ltd and Zenith Drugs Ltd

Which company has a larger market capitalization, Amwill Health Care Ltd or Zenith Drugs Ltd?

Market cap of Amwill Health Care Ltd is 72 Cr while Market cap of Zenith Drugs Ltd is 77 Cr

What are the key factors driving the stock performance of Amwill Health Care Ltd and Zenith Drugs Ltd?

The stock performance of Amwill Health Care Ltd and Zenith Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amwill Health Care Ltd and Zenith Drugs Ltd?

As of May 6, 2026, the Amwill Health Care Ltd stock price is INR ₹36.0. On the other hand, Zenith Drugs Ltd stock price is INR ₹45.35.

How do dividend payouts of Amwill Health Care Ltd and Zenith Drugs Ltd compare?

To compare the dividend payouts of Amwill Health Care Ltd and Zenith Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.